Spaventi S - Search Results

1

Local interferon therapy for melanoma patients.

Ikić D, Spaventi S, Padovan I, Kusić Z, Cajkovac V, Ivanković D, Daković N, Nola P. Ikić D, et al. Among authors: spaventi s. Int J Dermatol. 1995 Dec;34(12):872-4. doi: 10.1111/j.1365-4362.1995.tb04429.x. Int J Dermatol. 1995. PMID: 8647672

2

Interferon reduces recurrences of basal cell and squamous cell cancers.

Ikić D, Padovan I, Pipić N, Cajkovac V, Kusić Z, Daković N, Gregurek-Novak T, Soldo-Belić A, Spaventi S, Belicza M, et al. Ikić D, et al. Among authors: spaventi s. Int J Dermatol. 1995 Jan;34(1):58-60. doi: 10.1111/j.1365-4362.1995.tb04382.x. Int J Dermatol. 1995. PMID: 7896491

3

The expression and role of insulin-like growth factor II in malignant hemangiopericytomas.

Pavelić K, Spaventi S, Gluncić V, Matejcić A, Pavicić D, Karapandza N, Kusić Z, Lukac J, Dohoczky C, Cabrijan T, Pavelić J. Pavelić K, et al. Among authors: spaventi s. J Mol Med (Berl). 1999 Dec;77(12):865-9. doi: 10.1007/s001099900068. J Mol Med (Berl). 1999. PMID: 10682323

4

Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.

Pavelić K, Dedivitis RA, Kapitanović S, Cacev T, Guirado CR, Danić D, Radosević S, Brkić K, Pegan B, Krizanac S, Kusić Z, Spaventi S, Bura M. Pavelić K, et al. Among authors: spaventi s. Mutat Res. 2006 Jul 25;599(1-2):45-57. doi: 10.1016/j.mrfmmm.2006.01.021. Epub 2006 May 15. Mutat Res. 2006. PMID: 16698048 Free article.

5

Endemic goitre with adequate iodine intake.

Kusić Z, Simuncić EM, Daković N, Rak AK, Lukinac L, Spaventi S. Kusić Z, et al. Among authors: spaventi s. Lancet. 1990 May 19;335(8699):1229-30. doi: 10.1016/0140-6736(90)92760-f. Lancet. 1990. PMID: 1971079 No abstract available.

6

An evaluation of IRMA-TSH kits and a very sensitive RIA-TSH method.

Lukinac L, Kusić Z, Spaventi S, Simonović I. Lukinac L, et al. Among authors: spaventi s. Acta Med Iugosl. 1988;42(3):201-6. Acta Med Iugosl. 1988. PMID: 3213557 No abstract available.

7

[Our experience with the irradiation of reticulum cell sarcoma].

BASIC M, PADOVAN I, MILIC N, SPAVENTI S, POPOVIC L, BORIC D. BASIC M, et al. Among authors: spaventi s. Rad Med Fak Zagrebu. 1961;9:83-92. Rad Med Fak Zagrebu. 1961. PMID: 13865596 Undetermined Language. No abstract available.

8

Molecular genetics of malignant insulinoma.

Pavelic K, Hrascan R, Kapitanovic S, Vranes Z, Cabrijan T, Spaventi S, Korsic M, Krizanac S, Li YQ, Stambrook P, Gluckman JL, Pavelic ZP. Pavelic K, et al. Among authors: spaventi s. Anticancer Res. 1996 Jul-Aug;16(4A):1707-17. Anticancer Res. 1996. PMID: 8712689

9

Artificial reversion of acute myeloid leukemia cells into normal phenotype.

Pavelić K, Baltić V, Spaventi S. Pavelić K, et al. Among authors: spaventi s. Int J Biochem. 1990;22(5):533-8. doi: 10.1016/0020-711x(90)90269-9. Int J Biochem. 1990. PMID: 2189758

10

Immunohistochemical detection of TGF-alpha, EGF-R, c-erbB-2, c-H-ras, c-myc, estrogen and progesterone in benign and malignant human breast lesions: a concomitant expression.

Spaventi R, Kamenjicki E, Pecina N, Grazio S, Grazio S, Pavelic J, Kusic B, Cvrtila D, Danilovic Z, Spaventi S, et al. Spaventi R, et al. Among authors: spaventi s. In Vivo. 1994 Mar-Apr;8(2):183-9. In Vivo. 1994. PMID: 7919121

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page